Spyre Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(5.3%),VHCP Co-Investment Holdings III, LLC(5.3%)等
Spyre Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(5.7%),Joseph Edelman(5.7%)等
Spyre Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Commodore Capital LP(3.9%),Commodore Capital Master LP(3.9%)
Spyre Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Deep Track Capital, LP(1.97%),Deep Track Biotechnology Master Fund, Ltd.(1.97%)等
Spyre Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Avoro Capital Advisors LLC(1.7%),Behzad Aghazadeh(1.7%)
Spyre Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)
Spyre Therapeutics | 4:持股變動聲明-董事 Albers Jeffrey W.
Spyre Therapeutics | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(5.2%)
Spyre Therapeutics | 4:持股變動聲明-董事 Albers Jeffrey W.
Spyre Therapeutics | SC 13G:超過5%持股股東披露文件-Peter E. Deutsch(6.99%)
Spyre Therapeutics | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(5.2%)
Spyre Therapeutics | 4:持股變動聲明-高管 Sloan Sheldon
Spyre Therapeutics | 3:首次持股聲明-高管 Sloan Sheldon
Spyre Therapeutics | 4:持股變動聲明-高管 Burrows Scott L
Spyre Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(12.963%),Abigail P. Johnson(12.963%)
Spyre Therapeutics | 4:持股變動聲明-董事 Stelzer Laurie
Spyre Therapeutics | 4:持股變動聲明-董事 Albers Jeffrey W.
Spyre Therapeutics | 4:持股變動聲明-董事 Milligan Sandra
Spyre Therapeutics | 4:持股變動聲明-董事 Fairmount Funds Management LLC
Spyre Therapeutics | 4:持股變動聲明-董事 HENDERSON MICHAEL THOMAS